CAP TODAY/AstraZeneca Webinar: Liquid Biopsy Testing Strategies For Patients with Metastatic NSCLC

Thank you

This live web event has ended. Thank you for attending.

Description

Liquid Biopsy Testing Strategies
For Patients with Metastatic NSCLC

Why should you register now for this webinar?
Hear a national thought leader discuss the following topics:

Impact of implementing biomarker profiling on metastatic NSCLC
patient care
Benefits of integrating liquid biopsy testing with standard of care tissue-based testing on turnaround time and identification of patients with actionable biomarker mutations
How patient case scenarios demonstrate successes and challenges with integrating liquid biopsy and highlight unique considerations for its implementation

Brought to you by CAP TODAY
Moderated by Bob McGonnagle, Publisher, CAP TODAY
Presenter: Shirley Michelle Shiller, DO, MSPT
You will have the opportunity to ask questions to our distinguished presenter.

CAP TODAY does not endorse any of the products or services named within. This webinar is sponsored by AstraZeneca. ©2020 AstraZeneca. All rights reserved. US-40994 Last Updated 5/20

Contributors

Bob McGonnagle

Publisher, CAP TODAY
Shirley Michelle Shiller, DO, MSPT

Co-Medical Director
Division of Molecular Medicine and Pathology
Baylor Sammons Cancer Center
Baylor University Medical Center
Dallas, Texas